Abstract

BackgroundAnti-EGFR chemotherapy drugs cause skin toxicity due to high numbers of receptors in keratinocytes of the epidermis, sebaceous glands, epithelial hair follicles. Cetuximab treatment for metastatic colorectal cancer causes rash...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Management of cetuximab-induced skin toxicity with the prophylactic use of topical vitamin K1 cream
Janja Ocvirk
Radiology and Oncology | VOL. 44
Janja OcvirkJanja Ocvirk
01 Jan 2009
Evaluation of the additional prophylactic effect of topical steroid ointment to systemic minocycline against anti-epidermal growth factor antibody-induced skin toxicities in metastatic colorectal cancer treatment.
Yoshito Komatsu ... Kazuki Uchiyama
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | VOL. 32
Yoshito Komatsu, et. al.Yoshito Komatsu ... Kazuki Uchiyama
06 Dec 2023
Observations on the prophylactic use of vitamin K in the newborn infant
J.A James ... T.P Murphy
The Journal of Pediatrics | VOL. 56
J.A James, et. al.J.A James ... T.P Murphy
01 Mar 1960
Epidermal growth factor receptor (EGFR) inhibitor–related skin toxicity: Review of interim data from a phase II study (20060314) of panitumumab (pmab) with FOLFIRI in the first-line treatment of metastatic colorectal cancer (mCRC)
H Letocha ... L Mineur
Journal of Clinical Oncology | VOL. 27
H Letocha, et. al.H Letocha ... L Mineur
20 May 2009
View more papers

More From: European Journal of Hospital Pharmacy: Science and Practice

Paper Title
Journal
Date
Author
EAHP and GS1 publish report of UZ Leuven meeting on bedside scanning and medicines bar coding
Richard Price
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
Richard PriceRichard Price
19 May 2014
In peer review we trust—or do we?
Phil Wiffen
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
Phil WiffenPhil Wiffen
19 May 2014
European Parliament Committee approves €3 billion public-private partnership with industry on new medicine development
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
19 May 2014
Chapter 5: Appraising the evidence
Phil Wiffen ... Hao Lu
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
Phil Wiffen, et. al.Phil Wiffen ... Hao Lu
19 May 2014
View more papers